单孔机器人辅助根治性前列腺切除术与单纯前列腺切除术:系统综述与Meta分析
该系统综述纳入21项研究共1400例患者,评估单孔机器人辅助根治性前列腺切除术(SP-RARP)和单孔机器人辅助单纯前列腺切除术(SP-RASP)的围手术期、肿瘤学和功能结局,并对SP-RARP与多孔机器人辅助根治性前列腺切除术(MP-RARP)的8项比较研究进行Meta分析。结果显示SP-RARP与MP-RARP在多数结局上相似,SP组住院时间更短;SP-RASP住院时间更短且新发尿失禁率更低。
要点
- SP-RARP与MP-RARP在手术时间、导尿时间、疼痛评分、并发症率、控尿率、勃起功能率、切缘阳性率和生化复发方面结局相似。
- 敏感性分析后SP组住院时间更短(WMD -0.58,95%CI -1.17至-0.9,p<0.05)。
- SP-RASP与其他技术相比住院时间更短、新发尿失禁率更低,但术后IPSS、残余尿量和最大尿流率无差异。
核心结论
- SP平台可获得与MP-RARP总体相当的肿瘤学、功能学和围手术期结局。
- 按不同入路进行亚组分析未显示结局有显著差异。
- 研究的回顾性性质、有限的随访时间和所选中心相对较小的样本量可能影响这些结果。
研究设计与样本
- 系统综述与Meta分析,检索多个数据库,检索时间为2023年7月。
- 纳入前瞻性和回顾性原创文章,评估非转移性前列腺癌患者接受SP-RARP或良性前列腺增生手术候选者接受SP-RASP,无论是否与其他手术技术比较,评估围手术期、肿瘤学或功能结局。
- 共纳入21项研究共1400例患者,其中18项关于SP-RARP,3项关于SP-RASP;仅8项比较研究符合Meta分析条件。
- 平均随访时间为8.1(±5.8)个月。
主要发现
- SP-RARP与MP-RARP在手术时间、导尿时间、疼痛评分、并发症率、控尿率、勃起功能率、切缘阳性和生化复发方面结局相似。
- 敏感性分析后SP组住院时间更短(WMD -0.58,95%CI -1.17至-0.9,p<0.05)。
- 按腹膜外入路亚组分析未显示任何统计学差异,唯独SP腹膜外技术相比MP-RARP切缘阳性率更低。
- 总体上SP-RASP与其他技术相比住院时间更短、新发尿失禁率更低,而术后国际前列腺症状评分(IPSS)、残余尿量和最大尿流率无差异。
局限性
- 研究的回顾性性质可能影响结果。
- 有限的随访时间可能影响结果。
- 所选中心相对较小的样本量可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aim of our study was to review the current evidence on single port robot-assisted radical prostatectomy (SP-RARP) and SP robot-assisted simple prostatectomy (SP-RASP) procedures. METHODS: A comprehensive bibliographic search on multiple databases was conducted in July 2023. Studies were included if they assessed patients with non-metastatic prostate cancer or candidate for benign prostatic hyperplasia surgery (P) who underwent SP-RARP or SP-RASP, respectively, (I), compared or not with other surgical techniques (C), evaluating perioperative, oncological, or functional outcomes (O). Prospective and retrospective original articles were included (S). A meta-analysis of comparative studies between SP-RARP and MP-RARP was performed. RESULTS: A total of 21 studies investigating 1400 patients were included in our systematic review, 18 were related to SP-RARP while 3 to SP-RASP. Only 8 comparative studies were eligible for meta-analysis. Mean follow-up was 8.1 (±5.8) months. Similar outcomes were observed for SP-RARP and MP-RARP in terms of operative time, catheterization time, pain score, complications rate, continence and potency rates, positive surgical margin, and biochemical recurrence. Length of hospital stay was shorter in the SP group after sensitivity analysis (WMD -0.58, 95% IC -1.17 to -0.9, p < 0.05). Subgroup analysis by extraperitoneal approach did not show any statistical difference, except for a lower positive margins rate in the SP extraperitoneal technique compared to MP-RARP. Overall, SP-RASP exhibited shorter hospital stay and lower rate of de novo urinary incontinence when compared to other techniques, while no differences were reported in terms of postoperative International Prostate Symptom Score, post void residual and maximum flow. CONCLUSIONS: Overall comparable oncological, functional, and perioperative outcomes can be achieved with SP platform. Subgroup analysis by different approaches did not reveal significant variations in outcomes. However, the retrospective nature of the studies, the limited follow-up, and the relatively small sample size of selected Centers may impact these results.
引用
- Franco A, Ditonno F, Manfredi C, et al. Single port robot-assisted radical and simple prostatectomy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024. PMID: 38263281. doi:10.1038/s41391-024-00787-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。